Merck hosts virtual HIV investor event Aug. 3 after AIDS 2026 data presentations

MRK•2026-07-15

Merck to present HIV pipeline data at AIDS 2026

Merck will present new HIV treatment and prevention pipeline data at the International AIDS Conference in Rio de Janeiro on July 26-31, 2026.

Late-breaker sessions are set to feature Phase 3 week-48 results for once-weekly islatravir/lenacapavir switch regimens versus daily standard-of-care.

Merck hosts virtual HIV investor event Aug. 3 after AIDS 2026 data presentations

Merck to present HIV pipeline data at AIDS 2026

Related News

Cantor Equity Partners II Inc <SECZ.N>: Rosenblatt Securities initiates coverage with buy rating; target price $14

Warren Buffett likes Berkshire investments in Google, Apple -- CNBC

Conagra Brands forecasts annual profit below estimates

US stocks-Wall St futures tick up as investors weigh earnings; PayPal jumps

AgPlenus launches AI model to predict antifungal potency, expands ChemPass AI for Ag platform